Worth Noting: Among the data in the statin/muscle injury study mentioned below was this graphic illustrating the rocketing ascent of Lipitor over the past ten years compared to other statins. Do you suppose it could have anything to do with articleslikethese? Note that two of those studies were inherently designed to give the edge to atorvastatin over the comparison drug by using twice the dose. Nonetheless, they were published in our two most prestigious medical journals with nary a comment on their bias. Pharmaceutical companies and medical researchers certainly have a tendency to skew results favorably, but they're amply aided and abetted by the editors who publish their papers in the journals.
posted by Sydney on
11/23/2004 11:03:00 PM